Global Endoparasiticide Market Research Report 2021

1 Endoparasiticide Market Overview
    1.1 Product Overview and Scope of Endoparasiticide
    1.2 Endoparasiticide Segment by Type
        1.2.1 Global Endoparasiticide Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Ear Tags
        1.2.3 Tablets
        1.2.4 Injectables
        1.2.5 Feed Additives
    1.3 Endoparasiticide Segment by Application
        1.3.1 Endoparasiticide Sales Comparison by Application: (2021-2027)
        1.3.2 Veterinary Hospitals or Clinics
        1.3.3 Animal Farms
        1.3.4 Home Care Settings
    1.4 Global Endoparasiticide Market Size Estimates and Forecasts
        1.4.1 Global Endoparasiticide Revenue 2016-2027
        1.4.2 Global Endoparasiticide Sales 2016-2027
        1.4.3 Endoparasiticide Market Size by Region: 2016 Versus 2021 Versus 2027

2 Endoparasiticide Market Competition by Manufacturers
    2.1 Global Endoparasiticide Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Endoparasiticide Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Endoparasiticide Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Endoparasiticide Manufacturing Sites, Area Served, Product Type
    2.5 Endoparasiticide Market Competitive Situation and Trends
        2.5.1 Endoparasiticide Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Endoparasiticide Players Market Share by Revenue
        2.5.3 Global Endoparasiticide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Endoparasiticide Retrospective Market Scenario by Region
    3.1 Global Endoparasiticide Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Endoparasiticide Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Endoparasiticide Market Facts & Figures by Country
        3.3.1 North America Endoparasiticide Sales by Country
        3.3.2 North America Endoparasiticide Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Endoparasiticide Market Facts & Figures by Country
        3.4.1 Europe Endoparasiticide Sales by Country
        3.4.2 Europe Endoparasiticide Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Endoparasiticide Market Facts & Figures by Region
        3.5.1 Asia Pacific Endoparasiticide Sales by Region
        3.5.2 Asia Pacific Endoparasiticide Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Endoparasiticide Market Facts & Figures by Country
        3.6.1 Latin America Endoparasiticide Sales by Country
        3.6.2 Latin America Endoparasiticide Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Endoparasiticide Market Facts & Figures by Country
        3.7.1 Middle East and Africa Endoparasiticide Sales by Country
        3.7.2 Middle East and Africa Endoparasiticide Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Endoparasiticide Historic Market Analysis by Type
    4.1 Global Endoparasiticide Sales Market Share by Type (2016-2021)
    4.2 Global Endoparasiticide Revenue Market Share by Type (2016-2021)
    4.3 Global Endoparasiticide Price by Type (2016-2021)

5 Global Endoparasiticide Historic Market Analysis by Application
    5.1 Global Endoparasiticide Sales Market Share by Application (2016-2021)
    5.2 Global Endoparasiticide Revenue Market Share by Application (2016-2021)
    5.3 Global Endoparasiticide Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Boehringer Ingelheim
        6.1.1 Boehringer Ingelheim Corporation Information
        6.1.2 Boehringer Ingelheim Description and Business Overview
        6.1.3 Boehringer Ingelheim Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Boehringer Ingelheim Product Portfolio
        6.1.5 Boehringer Ingelheim Recent Developments/Updates
    6.2 Elanco
        6.2.1 Elanco Corporation Information
        6.2.2 Elanco Description and Business Overview
        6.2.3 Elanco Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Elanco Product Portfolio
        6.2.5 Elanco Recent Developments/Updates
    6.3 Zoetis
        6.3.1 Zoetis Corporation Information
        6.3.2 Zoetis Description and Business Overview
        6.3.3 Zoetis Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Zoetis Product Portfolio
        6.3.5 Zoetis Recent Developments/Updates
    6.4 Merck
        6.4.1 Merck Corporation Information
        6.4.2 Merck Description and Business Overview
        6.4.3 Merck Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Merck Product Portfolio
        6.4.5 Merck Recent Developments/Updates
    6.5 Virbac
        6.5.1 Virbac Corporation Information
        6.5.2 Virbac Description and Business Overview
        6.5.3 Virbac Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Virbac Product Portfolio
        6.5.5 Virbac Recent Developments/Updates
    6.6 Novartis AG
        6.6.1 Novartis AG Corporation Information
        6.6.2 Novartis AG Description and Business Overview
        6.6.3 Novartis AG Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Novartis AG Product Portfolio
        6.6.5 Novartis AG Recent Developments/Updates
    6.7 Ceva Sante Animlae
        6.6.1 Ceva Sante Animlae Corporation Information
        6.6.2 Ceva Sante Animlae Description and Business Overview
        6.6.3 Ceva Sante Animlae Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Ceva Sante Animlae Product Portfolio
        6.7.5 Ceva Sante Animlae Recent Developments/Updates
    6.8 Bayer AG
        6.8.1 Bayer AG Corporation Information
        6.8.2 Bayer AG Description and Business Overview
        6.8.3 Bayer AG Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Bayer AG Product Portfolio
        6.8.5 Bayer AG Recent Developments/Updates
    6.9 Eli Lilly
        6.9.1 Eli Lilly Corporation Information
        6.9.2 Eli Lilly Description and Business Overview
        6.9.3 Eli Lilly Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Eli Lilly Product Portfolio
        6.9.5 Eli Lilly Recent Developments/Updates
    6.10 Vetoquinol
        6.10.1 Vetoquinol Corporation Information
        6.10.2 Vetoquinol Description and Business Overview
        6.10.3 Vetoquinol Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Vetoquinol Product Portfolio
        6.10.5 Vetoquinol Recent Developments/Updates

7 Endoparasiticide Manufacturing Cost Analysis
    7.1 Endoparasiticide Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Endoparasiticide
    7.4 Endoparasiticide Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Endoparasiticide Distributors List
    8.3 Endoparasiticide Customers

9 Endoparasiticide Market Dynamics
    9.1 Endoparasiticide Industry Trends
    9.2 Endoparasiticide Growth Drivers
    9.3 Endoparasiticide Market Challenges
    9.4 Endoparasiticide Market Restraints

10 Global Market Forecast
    10.1 Endoparasiticide Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Endoparasiticide by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Endoparasiticide by Type (2022-2027)
    10.2 Endoparasiticide Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Endoparasiticide by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Endoparasiticide by Application (2022-2027)
    10.3 Endoparasiticide Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Endoparasiticide by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Endoparasiticide by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer